Efficacy, Tolerance, and Safety of Colestipol HCL as a
... hypocholesterolemic interventions. Circulation, 58:164. 4. Cooper, E.E. and Michel, A.M. (1975) Colestipol hydrochloride, a new hypolipidemic drug; a twoyear study. South Med. J; 68:3030. 5. Gundersen, K., Cooper, E.E., Ruoff, G., Nikolai, T. and Assenzo, J.R. (1976) 6. Cholesterol-lowering effect o ...
... hypocholesterolemic interventions. Circulation, 58:164. 4. Cooper, E.E. and Michel, A.M. (1975) Colestipol hydrochloride, a new hypolipidemic drug; a twoyear study. South Med. J; 68:3030. 5. Gundersen, K., Cooper, E.E., Ruoff, G., Nikolai, T. and Assenzo, J.R. (1976) 6. Cholesterol-lowering effect o ...
Rajini Ramana - The Cambridge MRCPsych Course
... A pooled odds ratio of 3.31 for response with lithium augmentation compared to response with placebo was found for the trials that used a minimum dose of 800 mg/day of lithium carbonate or a dose sufficient to obtain serum lithium levels of ≥0.5 meq/liter and had a minimum treatment duration of 2 we ...
... A pooled odds ratio of 3.31 for response with lithium augmentation compared to response with placebo was found for the trials that used a minimum dose of 800 mg/day of lithium carbonate or a dose sufficient to obtain serum lithium levels of ≥0.5 meq/liter and had a minimum treatment duration of 2 we ...
DEFINITION: Progressive and irreversible deterioration of
... - Prescribe fluid restriction - Treatment with erythropoietin - Monitoring of dosages of any drug treatment as excretion of drugs dependent on renal function - Phosphate binding treatment to decrease renal calcification - Anti-HTN treatment - Drug therapy to increase kidney excretion (eg: diuretics) ...
... - Prescribe fluid restriction - Treatment with erythropoietin - Monitoring of dosages of any drug treatment as excretion of drugs dependent on renal function - Phosphate binding treatment to decrease renal calcification - Anti-HTN treatment - Drug therapy to increase kidney excretion (eg: diuretics) ...
Immune Globulin IV Therapy: Optimizing Care of Patients in the
... autoimmune conditions and prophylaxis against viral infection. Conclusions: The safety and effectiveness of IGIV therapy depend on selection of an appropriate product, dosage, and infusion rate; patient comorbidities and other risk factors; and patient education and treatment adherence. Implications ...
... autoimmune conditions and prophylaxis against viral infection. Conclusions: The safety and effectiveness of IGIV therapy depend on selection of an appropriate product, dosage, and infusion rate; patient comorbidities and other risk factors; and patient education and treatment adherence. Implications ...
4 Mental Health Disorders in Parkinson`s Disease
... function (eg -synuclein). Areas affected by these inclusions usually also contain coiled bodies within glia, and signs of neuronal loss. In all cases (whether they start with parkinsonism or dementia) there are Lewy bodies in the substantia nigra, but also in other brainstem nuclei such as the nora ...
... function (eg -synuclein). Areas affected by these inclusions usually also contain coiled bodies within glia, and signs of neuronal loss. In all cases (whether they start with parkinsonism or dementia) there are Lewy bodies in the substantia nigra, but also in other brainstem nuclei such as the nora ...
event-driven studies and serious chronic diseases
... are dependent on patient motivation or clinical judgement. To eliminate this, there may be a preference for surrogate markers that measure biological processes: namely biomarkers.5 In RCTs and the clinical management of PAH, there is a need for biomarkers that identify the disease and are able to pr ...
... are dependent on patient motivation or clinical judgement. To eliminate this, there may be a preference for surrogate markers that measure biological processes: namely biomarkers.5 In RCTs and the clinical management of PAH, there is a need for biomarkers that identify the disease and are able to pr ...
AMIODARONE (CORDARONE)
... • Vital Signs: blood pressure, pulse, and respirations will be documented a minimum of every 15 minutes x 4 when intravenous push/continuous infusion is initiated or dosage is changed, then every 4 hours during continuous infusion 9.) Most Common Drug Incompatibilities (do not give through the same ...
... • Vital Signs: blood pressure, pulse, and respirations will be documented a minimum of every 15 minutes x 4 when intravenous push/continuous infusion is initiated or dosage is changed, then every 4 hours during continuous infusion 9.) Most Common Drug Incompatibilities (do not give through the same ...
extracorporeal shock wave therapy (eswt)
... in the treatment of kidney stones. That technology requires a large machine and an anesthetized patient, and is very expensive. About 12 years ago smaller, low energy, ESWT devices were developed in Europe to treat common painful tendon conditions that often resulted in calcium stones being deposite ...
... in the treatment of kidney stones. That technology requires a large machine and an anesthetized patient, and is very expensive. About 12 years ago smaller, low energy, ESWT devices were developed in Europe to treat common painful tendon conditions that often resulted in calcium stones being deposite ...
Flight Notes - Sanford Health
... It is imperative as a health care provider to determine medication compliance. Education is diligently provided to patients with heart failure, making it very important to question them regarding: • Current weight and any weight fluctuations • Recent salt intake • Emotional stressors • Recen ...
... It is imperative as a health care provider to determine medication compliance. Education is diligently provided to patients with heart failure, making it very important to question them regarding: • Current weight and any weight fluctuations • Recent salt intake • Emotional stressors • Recen ...
The French Emergency Medical System
... persistent seizure activity at ICU admission, that could be repeated up to three time, if necessary. Then, all patients with ongoing seizure activity received standard complementary intravenous anticonvulsant drugs (phenobarbital 10 to 15 mg/kg, phenytoin 18 mg/kg or equivalent dose of fosphenytoin) ...
... persistent seizure activity at ICU admission, that could be repeated up to three time, if necessary. Then, all patients with ongoing seizure activity received standard complementary intravenous anticonvulsant drugs (phenobarbital 10 to 15 mg/kg, phenytoin 18 mg/kg or equivalent dose of fosphenytoin) ...
Nusinersen: The Case for FDA Approval Now
... Set forth below are examples of drugs approved for treating rare diseases where the FDA’s flexibility and sensitivity to the obstacles of drug development for rare diseases brought forth a successful treatment. Many of the 357 approved orphan drugs were tested on limited numbers of patients, serving ...
... Set forth below are examples of drugs approved for treating rare diseases where the FDA’s flexibility and sensitivity to the obstacles of drug development for rare diseases brought forth a successful treatment. Many of the 357 approved orphan drugs were tested on limited numbers of patients, serving ...
Respiratory Tract Infections in Children
... head and neck examination was performed to exclude other diseases and all the patients were instructed to take Koflet-H lozenges 3 times a day for 6 days. No other medications or antiinflammatory drugs were taken during the study period. All the patients were evaluated for their presenting symptoms ...
... head and neck examination was performed to exclude other diseases and all the patients were instructed to take Koflet-H lozenges 3 times a day for 6 days. No other medications or antiinflammatory drugs were taken during the study period. All the patients were evaluated for their presenting symptoms ...
PANDAS and PANS - Kennedy Krieger Institute
... PANDAS is an abbreviation for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections. This term is used to describe a subset of children and adolescents who have Obsessive Compulsive Disorder (OCD) and/or tic disorders, an in whom symptoms worsen following a strep i ...
... PANDAS is an abbreviation for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections. This term is used to describe a subset of children and adolescents who have Obsessive Compulsive Disorder (OCD) and/or tic disorders, an in whom symptoms worsen following a strep i ...
AC05 - Symptomatic Bradycardia
... symptoms and pharmacological treatment given only when symptomatic, otherwise monitor and reassess frequently. • Identifying signs and symptoms of poor perfusion caused by bradycardia is paramount. • Atropine vs. pacing: Caution should be exercised in the setting of a suspected acute MI. The use of ...
... symptoms and pharmacological treatment given only when symptomatic, otherwise monitor and reassess frequently. • Identifying signs and symptoms of poor perfusion caused by bradycardia is paramount. • Atropine vs. pacing: Caution should be exercised in the setting of a suspected acute MI. The use of ...
Koāte®-DVI - Cairo University
... o The labels are being revised to include a warning to avoid use in patients with congenital long QT syndrome because these patients are at particular risk for Torsade. o Recommendations for ECG monitoring in patients with electrolyte abnormalities (e.g., hypokalemia or hypomagnesemia), congestive h ...
... o The labels are being revised to include a warning to avoid use in patients with congenital long QT syndrome because these patients are at particular risk for Torsade. o Recommendations for ECG monitoring in patients with electrolyte abnormalities (e.g., hypokalemia or hypomagnesemia), congestive h ...
Evidence Based Medicine - University of South Alabama
... reduction in serum alanine aminotransferase (ALT) levels after at least one month on the protocol. For all patients reviewed, the average reduction in ALT was 35 U/L (p=0.026). These data appear to suggest that a conservative approach using diet and lifestyle modification, along with safe and indica ...
... reduction in serum alanine aminotransferase (ALT) levels after at least one month on the protocol. For all patients reviewed, the average reduction in ALT was 35 U/L (p=0.026). These data appear to suggest that a conservative approach using diet and lifestyle modification, along with safe and indica ...
Chapter 33: FotoFacial RF Pro® Complications
... If the patient has diffuse or patchy swelling, redness and itching, (especially on non-treated skin surfaces such as the eyelids) you should suspect an allergic reaction to the topical anesthetic (usually the benzocaine in the “BLT” formulation). Treat with an antihistamine, topical steroid cream bu ...
... If the patient has diffuse or patchy swelling, redness and itching, (especially on non-treated skin surfaces such as the eyelids) you should suspect an allergic reaction to the topical anesthetic (usually the benzocaine in the “BLT” formulation). Treat with an antihistamine, topical steroid cream bu ...
Aesthetics Journal, Nov 2014
... region of the thigh, medial thigh area and medial zone around the knee and hips. However, usage in other areas of the body, as deemed suitable by the physician after careful assessment, is common in practice. With over two million vials sold in the past five years in 49 countries, Aqualysis is easil ...
... region of the thigh, medial thigh area and medial zone around the knee and hips. However, usage in other areas of the body, as deemed suitable by the physician after careful assessment, is common in practice. With over two million vials sold in the past five years in 49 countries, Aqualysis is easil ...
IN THE NAME OF GOD Systemic Effects of Oral Glucocorticoids
... those taking corticosteroids alone but there was an increased risk in those taking nonsteroidal anti-inflammatory drugs . when a patient is prescribed corticosteroid treatment who has risk factors for PUD such as a past history of PUD; smoking; high alcohol intake; or receiving ulcerogenic drugs(NSA ...
... those taking corticosteroids alone but there was an increased risk in those taking nonsteroidal anti-inflammatory drugs . when a patient is prescribed corticosteroid treatment who has risk factors for PUD such as a past history of PUD; smoking; high alcohol intake; or receiving ulcerogenic drugs(NSA ...
RGH Pharmacy E-Bulletin
... of persistent and intractable hiccups exist including infection, trauma, tumour, and gastrointestinal, metabolic and psychogenic disorders. The more common causes are ischaemic/haemorrhagic stroke, encephalitis, head trauma, goitre, pharyngitis, enlarged lymph nodes secondary to infection or neoplas ...
... of persistent and intractable hiccups exist including infection, trauma, tumour, and gastrointestinal, metabolic and psychogenic disorders. The more common causes are ischaemic/haemorrhagic stroke, encephalitis, head trauma, goitre, pharyngitis, enlarged lymph nodes secondary to infection or neoplas ...
Combination biologic therapy - Clinical and Experimental
... for patients using combinations of cytokine antagonists. Disadvantages of this approach may be, at worst, a requirement for long-term therapy and, at best, a requirement for long-term surveillance. An efficient and chronic blockade of TNFα production, for example, may increase the risk for severe an ...
... for patients using combinations of cytokine antagonists. Disadvantages of this approach may be, at worst, a requirement for long-term therapy and, at best, a requirement for long-term surveillance. An efficient and chronic blockade of TNFα production, for example, may increase the risk for severe an ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.